Free Webinar in October
Until the advent of the successful CAPTAIN-trials with Cerebrolysin®, one of the most important unmet needs in medicine has been the treatment of severe and moderate traumatic brain injury with evidence-based pharmacological agents.
We invite you to join our webinar on October 12th, at 12:00 -13:30 (CEST).
Our speakers will present to you with innovative preclinical and clinical treatment concepts for severe TBI patients, innovative educational programs focusing on this highly complex medical problem and innovative biometric approaches solving the historical trial design failures in TBI trials.
Programme:
- New vistas in TBI clinical research - on the way towards a new gold standard
Johannes C. Vester
Head Biometry & Clinical Research
IDV Data Analysis and Study Planning, Gauting, Germany
- Best supportive care in TBI: new hope from combined neuroprotective agents?
Helmut Trimmel
Head of Anaesthesia, Emergency and General Intensive Care Medicine
Landesklinikum Wiener Neustadt, Austria
- Post Intensive Care Syndrome: neurotrophic factor hypothesis
Ignacio J. Previgliano
Hospital General de Agudos J. A. Fernández
Buenos Aires Ciry – Argentina
- Innovative concepts for increasing awareness of multidisciplinary treatment after TBI.
Peter Lackner
Head of Department of Neurology, Clinic Floridsdorf, Vienna, Austria
Also experience our webinar-platform, which allows participants to:
- Life simultaneous translation in Russian
- English subtitles
To register for the webinar please go to https://webinars-everpharma.com/